Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ISOLATED ANTIGEN-BINDING PROTEIN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/002266
Kind Code:
A1
Abstract:
Provided is an isolated antigen-binding protein capable of specifically binding to LILRB4 protein. Also provided are a polypeptide comprising the isolated antigen-binding protein, a fusion protein, a drug molecule, a nucleic acid encoding the isolated antigen-binding protein, a vector comprising the isolated antigen-binding protein, a cell comprising the nucleic acid or the vector, a method for preparing the isolated antigen-binding protein, and use of the isolated antigen-binding protein.

Inventors:
LV MING (CN)
DING XIAORAN (CN)
MIAO SHIWEI (CN)
TAN BIN (CN)
TAO JUN (CN)
CUI HANG (CN)
Application Number:
PCT/CN2023/104012
Publication Date:
January 04, 2024
Filing Date:
June 29, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANGZHOU SUMGEN BIOTECH CO LTD (CN)
SUMGEN MAB BEIJING BIOTECH CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00
Domestic Patent References:
WO2021183839A22021-09-16
WO2020180789A12020-09-10
WO2006138739A22006-12-28
WO2013033734A12013-03-07
Foreign References:
CN114531851A2022-05-24
US20190241655A12019-08-08
Attorney, Agent or Firm:
SHANGHAI DIANSHI PARTNERS , P.C. et al. (CN)
Download PDF: